Earum Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 84.23 million compared to INR 91.08 million a year ago. Revenue was INR 106.23 million compared to INR 99.17 million a year ago. Net income was INR 54 million compared to net loss of INR 9.87 million a year ago. Basic earnings per share from continuing operations was INR 0.876 compared to basic loss per share from continuing operations of INR 0.16 a year ago. Diluted earnings per share from continuing operations was INR 0.876 compared to diluted loss per share from continuing operations of INR 0.16 a year ago.
For the six months, sales was INR 114.1 million compared to INR 388.51 million a year ago. Revenue was INR 136.93 million compared to INR 418.38 million a year ago. Net income was INR 19.87 million compared to net loss of INR 16.27 million a year ago. Basic earnings per share from continuing operations was INR 0.312 compared to basic loss per share from continuing operations of INR 0.264 a year ago. Diluted earnings per share from continuing operations was INR 0.312 compared to diluted loss per share from continuing operations of INR 0.264 a year ago.